ClinConnect ClinConnect Logo
Search / Trial NCT03757091

Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery

Launched by M.D. ANDERSON CANCER CENTER · Nov 27, 2018

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how two different tools—one called a flexible intubation scope and the other a video laryngoscope—can help doctors place a breathing tube in patients with head and neck cancer before their surgery. These tools have small cameras that allow the doctor to see the patient’s airway clearly on a screen, which can help reduce the chances of complications during the procedure, such as pain or injuries to the mouth.

To be eligible for this trial, participants must be at least 18 years old and have specific conditions that might make it harder for doctors to place the breathing tube. This includes having certain physical features or medical history that could complicate the intubation process. If you join the study, you will have the opportunity to help researchers understand which method works best for patients like you. It’s important to note that the trial is currently recruiting participants, and those considering joining should be aware that they will need to provide written consent to participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Ages ≥ 18 years of age
  • All surgical patients with known or suspected difficult airways that meet at least three (3) of the Difficult Airway criteria \[Mallampati III-IV, Neck circumference \> 40 cm, Sternomental distance \< 12 cm, Thyromental distance \< 6 cm, Mouth opening \< 4 cm, BMI ≥ 35 kg/m2, Upper Lip Bite Test - ULBT (class III)\] or history of radiation to the head and neck area or oral pathology obstructing the glottic view
  • American Society of Anesthesiology (ASA) I-IV
  • Has provided written informed consent
  • Exclusion Criteria:
  • Active bleeding from nasopharynx or oropharynx
  • Trismus
  • Oral pathology obstructing the glottic view
  • Planned awake or nasal intubation
  • Neuromuscular Blockade (NMB) contraindicated post-induction
  • Emergency endotracheal intubation and patients intubated pre and post-surgery
  • Surgical procedures such as Tracheostomy, Laryngectomy, Esophagectomy
  • Patient refusal or inability to consent for study participation
  • American Society of Anesthesiology (ASA) V
  • Pregnant females

About M.D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Carin Hagberg

Principal Investigator

M.D. Anderson Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials